Stay updated on Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial
Sign up to get notified when there's something new on the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page.

Latest updates to the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page
- Check3 days agoChange DetectedThe page’s Locations section was updated to include a full list of participating U.S. states and the revision tag v3.3.3; the prior v3.3.2 state locations were removed, and the HHS Vulnerability Disclosure link was deleted.SummaryDifference2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe Osteoarthritis term and the related topic MedlinePlus Genetics were removed from the page.SummaryDifference0.1%

- Check24 days agoChange DetectedAdded 'Osteoarthritis' and related topic annotations, including MedlinePlus Genetics and a PubMed-related note. Removed the older PubMed publication description and updated the revision note to v3.3.2.SummaryDifference0.2%

- Check31 days agoChange DetectedRemoved the general government funding–related operating status notice. The study details, eligibility criteria, and listed sites remain unchanged.SummaryDifference0.2%

- Check46 days agoChange DetectedOsteoarthritis and MedlinePlus Genetics were added to the page's related topics.SummaryDifference0.1%

- Check53 days agoChange DetectedNo significant changes detected to core study content; the updates seem to be minor UI/layout adjustments only. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page.